CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
77 hedge funds and large institutions have $145M invested in Concert Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 30 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
-3
Holders Change %
-3.75%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
24
Reduced
30
Closed
14
Calls
$174K
Puts
$380K
Net Calls
-$206K
Net Calls Change
+$989K
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
$13.9M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
$3.04M |
| 3 |
Morgan Stanley
New York
|
$569K |
| 4 |
ISL
Ingalls & Snyder LLC
New York
|
$13.5M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$763K |
